Zogenix: Zogenix : Amendment to Annual Report (Form 10-K/A)
(marketscreener.com) 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ☒ ...https://www.marketscreener.com/quote/stock/ZOGENIX-INC-22779450/news/Zogenix-Amendment-to-Annual-Report-Form-10-K-A-39684380/?utm_medium=RSS&utm_content=20220307
Read full article »
Zogenix is a California-based biopharmaceutical company that develops and commercializes transformative therapies for the treatment of epilepsy and mitochondrial diseases.
Read more